Simple Science

Cutting edge science explained simply

# Health Sciences # HIV/AIDS

Advancements in HIV Treatment Predictions in Colombia

A study compares models to predict HIV treatment success in Colombia.

Alexandra Porras-Ramírez, A. Buitrago-Gutierrez, A. Porras-Ramirez

― 6 min read


HIV Treatment Predictions HIV Treatment Predictions in Colombia HIV treatment success. Study evaluates models for predicting
Table of Contents

HIV stands for Human Immunodeficiency Virus, a virus that attacks the immune system, making it hard for the body to fight off infections. If not treated, HIV can lead to AIDS, which is Acquired Immunodeficiency Syndrome. People with AIDS have very weak immune systems and can easily get sick from infections or even diseases that healthy people can fight off.

HIV and AIDS remain serious public health issues, especially in developing countries. Organizations like UNAIDS have set goals to combat this disease worldwide. Their aim for 2020 was the "90-90-90" target: to have 90% of people living with HIV diagnosed, 90% of those diagnosed on Treatment, and 90% of those on treatment achieving viral suppression. Recently, they revised this target to 95% by the year 2030.

Growth of HIV Cases in Colombia

In Colombia, data shows a sharp increase in HIV cases. From 35,000 cases in 2012, the number surged to 123,490 by 2020. This rise emphasizes the need for effective strategies to manage and treat HIV. The Colombian health system has a database that tracks high-cost diseases, including HIV, which helps monitor and report the care of people living with HIV in the country.

The Role of Technology in Managing HIV

To better handle HIV, healthcare providers are turning to technology and data analysis. By using tools like machine learning, which is a way for computers to learn and make decisions, doctors can create models that help predict how patients will respond to treatment. This could lead to more personalized care for patients.

In Colombia, the SISCAC system provides a wealth of data that can be used for these predictive models. The use of technology in healthcare aims to improve patient experiences, lower costs, and enhance the work conditions of healthcare workers.

Previous Research on HIV Treatment

Several studies have looked at how data can inform treatment for HIV. One study assessed patients using data from electronic medical records to identify factors that lead to treatment failure in patients who started care within their first year of diagnosis. Another research focused on using artificial Neural Networks, a type of machine learning, to predict how patients respond to treatment based on their clinical data.

A neural network processes information similarly to how the human brain works. It takes input data, processes it through various layers, and produces an output. Researchers have found that these models can predict patient outcomes based on several treatment variables, similar to more traditional methods like logistic regression.

Study Objective

This study aimed to assess how well different models predict the success of treatment in HIV patients in Colombia. Researchers wanted to see if using a neural network could offer better predictions compared to traditional logistic regression models. They specifically looked at three outcome measures: having a suppressed Viral Load (less than 200 copies/mL), having an undetectable viral load (less than 20 copies/mL), and having a sufficient CD4 lymphocyte count (above 350 cells/mm3) at the end of 12 months of treatment.

Methods Used in the Study

The research analyzed anonymous data from HIV patients treated at a specialized facility in Bogotá, Colombia. The study included adults (18 years and older) who had been followed for one year. The researchers used data on various demographic and clinical characteristics, such as age, sex, and medical history, to assess their impact on treatment outcomes.

The study followed strict ethical guidelines and had approval from the relevant ethics committee. It relied on data already collected for healthcare purposes, ensuring that patient identities remained confidential.

Data Analysis

For the analysis, researchers looked at several demographic factors, such as age, sex, and weight, along with clinical aspects of HIV infection. They also considered factors like the years since diagnosis, the HIV transmission route, the CD4 count, and the viral load at the start of treatment.

The data included records of treatment compliance, number of consultations with specialists, and whether patients switched medications during the study period. By categorizing these variables, researchers could look for trends related to treatment success.

Outcomes of the Study

The main outcomes evaluated were viral load suppression, undetectability, and immune recovery after 12 months of treatment.

Viral Load Outcomes

For the outcome of suppressed viral load, several significant variables were identified. These included:

  • Stage of HIV at diagnosis
  • Coinfection with hepatitis C
  • Changes in antiretroviral therapy
  • Adherence to treatment
  • Number of consultations with infectious disease specialists

The analysis showed that patients who were more adherent to their treatment and who had more frequent consultations with specialists had better outcomes.

Similarly, for undetectable viral load, significant factors included:

  • Stage of HIV at diagnosis
  • Viral load at the start of treatment
  • Coinfection with hepatitis C
  • Changes in therapy
  • Treatment adherence

In both cases, good adherence to treatment was a key predictor of success.

Immunological Reconstitution

For immunological recovery, which is measured by CD4 counts, factors like the initial stage of HIV, viral load at treatment start, active tuberculosis, use of integrase inhibitors, therapy changes, adherence, and frequent consultations with specialists were found to be significant predictors of success.

The study found that the models were successful in predicting treatment outcomes, with the neural network showing strong performance, especially in determining immune recovery, compared to traditional logistic regression.

Comparison of Prediction Models

The study compared the two types of models: the traditional logistic regression and the newer neural network approach. While both models showed decent accuracy in predicting treatment outcomes, the neural networks performed slightly better, particularly in the area of immune recovery.

This indicates that machine learning models, while requiring a significant amount of data for training, can enhance the predictions regarding treatment success for HIV patients.

Strengths and Limitations of the Study

The advantages of the study include its use of comprehensive data and advanced modeling techniques, allowing for nuanced analysis of factors impacting treatment outcomes. Additionally, the inclusion of a diverse patient population from multiple cities in Colombia strengthens the findings.

However, there were limitations, such as the reliance on a single healthcare provider's data which could introduce biases. The study also highlighted challenges with neural networks, such as the need for large datasets and the complexity of interpreting results as the models could become a "black box."

Conclusion

Overall, the study underscores the potential of technology, specifically machine learning, to improve HIV treatment outcomes through better predictive models. While traditional methods still hold value, integrating new technologies could enhance patient care and lead to better health outcomes for people living with HIV.

This research encourages further exploration of technological advancements in healthcare, aiming to refine strategies in the management of HIV and related health issues. By continually assessing and improving how patient data is utilized, healthcare providers can offer more effective, personalized treatment options.

Original Source

Title: Artificial neural networks to predict virological and immunological success in HIV patients under antiretroviral therapy from a nationwide cohort in Colombia, using the SISCAC database.

Abstract: ObjectiveThis study aimed to develop predictive models both for viral suppression and immunological reconstitution using a standard set of reported variables in a nationwide database system (SISCAC) from a cohort of patients living with HIV in Colombia. Materials and MethodsWe included 2.182 patients with no missing data related to the outcomes of interest, during a 12 month follow up period. We randomly assigned a 0,7 proportion of this cohort to de training dataset for 2 different predictive models (logistic regression, artificial neural networks). The AUC/ROC results were compared with those obtained through the construction of artificial neural networks with the specified parameters. ResultsFrom a cohort of 2182 patients, 85,79% were male and at HIV diagnosis, the mean value of the CD4 count was 342 x mm3. The logistic regression models obtained AUC/ROC accuracy for the outcomes "suppressed viral load" 0,7, "undetectable viral load" of 0,66 and "immunological reconstitution" 0,83; whereas the artificial neural network perceptron multilayer obtained AUC/ROC of 0,77, 0.69 and 0,87 for the same outcomes. ConclusionsThe selection of specific variables from a nationwide database in Colombia with quality control purposes allowed us to generate predictive models with an initial evaluation of performance regarding three predefined outcomes for virological and immunological success.

Authors: Alexandra Porras-Ramírez, A. Buitrago-Gutierrez, A. Porras-Ramirez

Last Update: 2024-10-28 00:00:00

Language: English

Source URL: https://www.medrxiv.org/content/10.1101/2024.10.26.24316181

Source PDF: https://www.medrxiv.org/content/10.1101/2024.10.26.24316181.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to medrxiv for use of its open access interoperability.

Similar Articles